Lara Bischof

Impact of MRD status in patients with AML undergoing allogeneic stem cell transplantation in the first vs the second remission

Madlen Jentzsch, Lara Bischof, Donata Backhaus et al. · Blood Advances · 2022 · 48 citations · Full text

Medicine, Genetics, Hematology +15

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation

Madlen Jentzsch, Lara Bischof, Jule Ussmann et al. · Blood Cancer Journal · 2022 · 48 citations · Full text

Medicine, Hematology, Cancer Genetics +12

Impact of<i>IDH1</i>and<i>IDH2</i>mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation

Marius Bill, Madlen Jentzsch, Lara Bischof et al. · Blood Advances · 2022 · 34 citations · Full text

Life Sciences, Genetics, Hematology +14

A high hematopoietic cell transplantation comorbidity Index (HCT-CI) does not impair outcomes after non-myeloablative allogeneic stem cell transplantation in acute myeloid leukemia patients 60 years or older

Donata Backhaus, Dominic Brauer, Rosmarie Pointner et al. · Bone Marrow Transplantation · 2022 · 23 citations · Full text

Medicine, Hematology, Oncology +15